Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

Study of Biomarkers of Airway Inflammation (0000-128)

NCT00869596 ·Status: COMPLETED ·Phase: PHASE1

Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

NCT01715493 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis

NCT00255983 ·Status: TERMINATED ·Phase: PHASE3

Effect of Ensifentrine on Sputum Markers of Inflammation in COPD

NCT05270525 ·Status: RECRUITING ·Phase: PHASE2

Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough

NCT05495243 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

NCT07088926 ·Status: RECRUITING ·Phase: PHASE2

Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

NCT00205647 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

NCT05238675 ·Status: COMPLETED ·Phase: PHASE2

A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

NCT04656275 ·Status: TERMINATED ·Phase: PHASE1

Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa

NCT03715322 ·Status: UNKNOWN ·Phase: PHASE3

PH-797804 LPS Study in Healthy Volunteers

NCT02084485 ·Status: COMPLETED ·Phase: PHASE1

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis

NCT00769119 ·Status: COMPLETED ·Phase: PHASE2

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

NCT00639496 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis

NCT02637310 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

NCT05415137 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis

NCT01818544 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)

NCT01855230 ·Status: COMPLETED ·Phase: PHASE2

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

NCT03218917 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD

NCT06533553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)

NCT02105961 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects

NCT02058407 ·Status: TERMINATED ·Phase: PHASE1

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis

NCT04631016 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

NCT06559150 ·Status: RECRUITING ·Phase: PHASE2

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

NCT04308681 ·Status: COMPLETED ·Phase: PHASE2